Replimune plans layoffs as FDA rejects cancer drug

Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.
XDA Developers on MSN

Claude Code's leaked source code revealed some features Anthropic wasn't ready to share yet

Oops. A 60MB source map file just leaked Anthropic's entire roadmap.